BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...

The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.

NEW YORK – Irish diagnostic firm Trinity Biotech announced on Wednesday that it has entered into a $25 million standby equity purchase agreement with an affiliate of its financing partner Yorkville ...

The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.

The interferon-gamma release assay for latent tuberculosis infection is designed for use on Diasorin's automated, high-throughput Liaison XL platform.

Last week, readers were most interested in a story about a deal between QuidelOrtho and Shenzhen Lifotronic Technology covering immunoassays.

The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and ...

The transition from testing the dead to testing the living is the latest example of how genomics is expanding horizons for ...

Labcorp said it will be using the company's FDA-cleared AISight Dx platform across its national network of anatomic pathology labs and hospital collaborations.

The cleared assays included point-of-care and home tests for infectious and chronic diseases and drugs of abuse.

The agreement pertains to multiple immunoassay analyzers and test menus that QuidelOrtho expects will increase its competitiveness in international tenders.

The researchers measured the variation in DNA methylation patterns to develop the method and applied it to multiple types of cancer.